Authors: EVANS CP GAJENDRAN V TEWARI A ASLAM K JUSTER R GANGE S EASON A NARAYAN P

Citation: Cp. Evans et al., THE PROPORTIONAL DECREASE IN PROSTATE-SPECIFIC ANTIGEN LEVEL BEST PREDICTS THE DURATION OF SURVIVAL AFTER HORMONAL-THERAPY IN PATIENTS WITHMETASTATIC CARCINOMA OF THE PROSTATE, British Journal of Urology, 78(3), 1996, pp. 426-431

Authors: FOURNIER G INDUDHARA R GAJENDRAN V HUANG E NARAYAN P

Citation: G. Fournier et al., EPIDIDIMOORCHITIS AFTER CRYOABLATION OF PROSTATE FOR PROSTATE-CANCER, Journal of endourology, 9(4), 1995, pp. 349-351

Authors: NARAYAN P GAJENDRAN V TAYLOR SP TEWARI A PRESTI JC LEIDICH R LO R PALMER K SHINOHARA K SPAULDING JT

Citation: P. Narayan et al., THE ROLE OF TRANSRECTAL ULTRASOUND-GUIDED BIOPSY-BASED STAGING, PREOPERATIVE SERUM PROSTATE-SPECIFIC ANTIGEN, AND BIOPSY GLEASON SCORE IN PREDICTION OF FINAL PATHOLOGICAL DIAGNOSIS IN PROSTATE-CANCER, Urology, 46(2), 1995, pp. 205-212

Authors: NARAYAN P TEWARI A JACOB G MAHMOOD I GAJENDRAN V PRESTI J

Citation: P. Narayan et al., DIFFERENTIAL SUPPRESSION OF SERUM PROSTATIC ACID-PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN BY 5-ALPHA-REDUCTASE INHIBITOR, British Journal of Urology, 75(5), 1995, pp. 642-646

Authors: NARAYAN P FOURNIER G GAJENDRAN V LEIDICH R LO R WOLF JS JACOB G NICOLAISEN G PALMER K FREIHA F

Citation: P. Narayan et al., UTILITY OF PREOPERATIVE SERUM PROSTATE-SPECIFIC ANTIGEN CONCENTRATIONAND BIOPSY GLEASON SCORE IN PREDICTING RISK OF PELVIC LYMPH-NODE METASTASES IN PROSTATE-CANCER, Urology, 44(4), 1994, pp. 519-524